Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen and Progesterone in Bipolar Affective Disorder in Women
NCT00206544Phase 2Completed
- Sponsor
- Alfred Health
- Start
- Jan 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen, progesterone in bipolar disorder (BD), schizoaffective disorder, sponsored by Alfred Health. Started Jan 2004; status: completed.
02
Drugs
tamoxifenprogesterone
03
Conditions
bipolar disorder (BD)schizoaffective disorder
Beyond the preview
Go deeper on NCT00206544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206544.